Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population

Journal of Viral Hepatitis

Volumn 20, Issue 10, 2013, Pages 678-686

  Ezzikouri, S ^a   Kitab, B ^a   Rebbani, K ^a   Marchio, A ^b   Wain Hobson, S ^c   Dejean, A ^b   Vartanian, J P ^c   Pineau, P ^b   Benjelloun, S ^a  

^a Institut Pasteur du Maroc   (Morocco)

^b INSERM   (France)

^c INSTITUT PASTEUR   (France)

Author keywords

3D PCR; APOBEC3; cytidine deaminases; HBV; hypermutation; polymorphisms

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; HYDROLASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HEMIZYGOTE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; IN VIVO STUDY; MALE; MOROCCO; NONHUMAN; PRIORITY JOURNAL; VIRUS GENOME; VIRUS LOAD;

3D-PCR; APOBEC3; CYTIDINE DEAMINASES; HBV; HYPERMUTATION; POLYMORPHISMS;

ADULT; AGED; CARRIER STATE; CYTIDINE DEAMINASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; MOROCCO; POLYMORPHISM, GENETIC;

EID: 84884166065     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12042     Document Type: Article

References (43)

1. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV,. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004; 38: S158-S168.
2. Lai CL, Ratziu V, Yuen MF, Poynard T,. Viral hepatitis B. Lancet 2003; 362: 2089-2094.
3. Ezzikouri S, Chemin I, Chafik A, et al,. Genotype determination in Moroccan hepatitis B chronic carriers. Infect Genet Evol 2008; 8: 306-312.
4. Laskus T, Radkowski M, Lupa E, Horban A, Cianciara J, Slusarczyk J,. Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol 1992; 15: 174-178.
5. Sheen IS, Liaw YF, Lin DY, Chu CM,. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994; 170: 358-361.
6. Lin TM, Chen CJ, Wu MM, et al,. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989; 9: 737-741.
7. Kao PC, Wu JF, Ni YH, et al,. Tumour necrosis factor-alpha promoter region polymorphisms affect the course of spontaneous HBsAg clearance. Liver Int 2010; 30: 1448-1453.
8. Zhou J, Huang JD, Poon VK, et al,. Functional dissection of an IFN-alpha/beta receptor 1 promoter variant that confers higher risk to chronic hepatitis B virus infection. J Hepatol 2009; 51: 322-332.
9. Ben-Ari Z, Mor E, Papo O, et al,. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98: 144-150.
10. Kidd JM, Newman TL, Tuzun E, Kaul R, Eichler EE,. Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet 2007; 3: e63.
11. An P, Bleiber G, Duggal P, et al,. APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 2004; 78: 11070-11076.
12. Abe H, Ochi H, Maekawa T, et al,. Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection. Hepatol Res 2009; 39: 1159-1168.
13. Rosler C, Kock J, Kann M, et al,. APOBEC-mediated interference with hepadnavirus production. Hepatology 2005; 42: 301-309.
14. Noguchi C, Imamura M, Tsuge M, et al,. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection. J Infect Dis 2009; 199: 1599-1607.
15. Noguchi C, Ishino H, Tsuge M, et al,. G to A hypermutation of hepatitis B virus. Hepatology 2005; 41: 626-633.
16. Suspene R, Guetard D, Henry M, Sommer P, Wain-Hobson S, Vartanian JP,. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102: 8321-8326.
17. Lei YC, Hao YH, Zhang ZM, et al,. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. World J Gastroenterol 2006; 12: 4492-4497.
18. Rosler C, Kock J, Malim MH, Blum H, Evon Weizsacker F,. Comment on "Inhibition of hepatitis B virus replication by APOBEC3G". Science 2004; 305: 1403. author reply 1403.
19. Turelli P, Mangeat B, Jost S, Vianin S, Trono D,. Inhibition of hepatitis B virus replication by APOBEC3G. Science 2004; 303: 1829.
20. Henry M, Guetard D, Suspene R, Rusniok C, Wain-Hobson S, Vartanian JP,. Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS One 2009; 4: e4277.
21. Vartanian JP, Henry M, Marchio A, et al,. Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 2010; 6: e1000928.
22. Chemin I, Zoulim F, Merle P, et al,. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001; 34: 447-454.
23. Kitab B, Essaid El Feydi AE, Afifi R, et al,. Variability in the Precore and Core Promoter Regions of HBV Strains in Morocco: Characterization and Impact on Liver Disease Progression. PLoS One 2012; 7: e42891.
24. Shi YY, He L,. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97-98.
25. Li Z, Zhang Z, He Z, et al,. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Res 2009; 19: 519-523.
26. Delebecque F, Suspene R, Calattini S, et al,. Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol 2006; 80: 605-614.
27. Lochelt M, Romen F, Bastone P, et al,. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad Sci USA 2005; 102: 7982-7987.
28. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D,. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003; 424: 99-103.
29. Russell RA, Wiegand HL, Moore MD, Schafer A, McClure MO, Cullen BR,. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol 2005; 79: 8724-8731.
30. Tsuge M, Noguchi C, Akiyama R, et al,. G to A hypermutation of TT virus. Virus Res 2010; 149: 211-216.
31. Malim MH,. APOBEC proteins and intrinsic resistance to HIV-1 infection. Philos Trans R Soc Lond B Biol Sci 2009; 364: 675-687.
32. Zhang W, Zhang X, Tian C, et al,. Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression. Cell Microbiol 2008; 10: 112-121.
33. Bonvin M, Greeve J,. Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro. J Gen Virol 2007; 88: 3270-3274.
34. Baumert TF, Rosler C, Malim M, Hvon Weizsacker F,. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 2007; 46: 682-689.
35. Nguyen DH, Hu J,. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids. J Virol 2008; 82: 6852-6861.
36. Zhao D, Wang X, Lou G, et al,. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems. Virus Res 2010; 151: 213-219.
37. Valcke HS, Bernard NF, Bruneau J, Alary M, Tsoukas CM, Roger M,. APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians. Aids 2006; 20: 1984-1986.
38. Eidinger D, Garrett TJ,. Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J Exp Med 1972; 136: 1098-1116.
39. Butterworth M, McClellan B, Allansmith M,. Influence of sex in immunoglobulin levels. Nature 1967; 214: 1224-1225.
40. Pauklin S, Sernandez IV, Bachmann G, Ramiro AR, Petersen-Mahrt SK,. Estrogen directly activates AID transcription and function. J Exp Med 2009; 206: 99-111.
41. Bonvin M, Achermann F, Greeve I, et al,. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006; 43: 1364-1374.
42. Tanaka Y, Marusawa H, Seno H, et al,. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem Biophys Res Commun 2006; 341: 314-319.
43. Gunther S, Sommer G, Plikat U, et al,. Naturally occurring hepatitis B virus genomes bearing the hallmarks of retroviral G->A hypermutation. Virology 1997; 235: 104-108.